Drug Type Biological products |
Synonyms EBI-018, EBI-028, EBI-029 |
Target |
Action inhibitors |
Mechanism IL-17 inhibitors(Interleukin-17 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Dystrophy, Macular | Preclinical | - | - | |
| Ocular inflammation | Preclinical | - | - | |
| Uveitis | Preclinical | - | - |





